Notice Title

Consent to the Distribution of New Medicines

Publication Date
31 Mar 2022

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2022-go1197
Title
View PDF
File Type and Size
PDF (34 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Aspirin Tab – AFT
Active Ingredient: Aspirin 75mg
Dosage Form: Enteric coated tablet
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Micro Labs Limited, Hosur, India
   
Product: Aspirin Tab – AFT
Active Ingredient: Aspirin 100mg
Dosage Form: Enteric coated tablet
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Micro Labs Limited, Hosur, India
   
Product: Loraclear Soft Gel Caps
Active Ingredient: Loratadine 10mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: XL Laboratories Pvt. Limited, Neemrana, India


Dated this 29th day of March 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).